1. Home
  2. XYLO vs GNE Comparison

XYLO vs GNE Comparison

Compare XYLO & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • GNE
  • Stock Information
  • Founded
  • XYLO 1999
  • GNE 2011
  • Country
  • XYLO Israel
  • GNE United States
  • Employees
  • XYLO N/A
  • GNE N/A
  • Industry
  • XYLO
  • GNE Power Generation
  • Sector
  • XYLO
  • GNE Utilities
  • Exchange
  • XYLO NYSE
  • GNE Nasdaq
  • Market Cap
  • XYLO 3.8M
  • GNE 402.0M
  • IPO Year
  • XYLO N/A
  • GNE N/A
  • Fundamental
  • Price
  • XYLO $5.20
  • GNE $16.59
  • Analyst Decision
  • XYLO
  • GNE
  • Analyst Count
  • XYLO 0
  • GNE 0
  • Target Price
  • XYLO N/A
  • GNE N/A
  • AVG Volume (30 Days)
  • XYLO 23.6K
  • GNE 47.9K
  • Earning Date
  • XYLO 05-16-2025
  • GNE 05-06-2025
  • Dividend Yield
  • XYLO N/A
  • GNE 1.84%
  • EPS Growth
  • XYLO N/A
  • GNE 10.33
  • EPS
  • XYLO N/A
  • GNE 0.55
  • Revenue
  • XYLO $29,858,000.00
  • GNE $442,321,000.00
  • Revenue This Year
  • XYLO $16.76
  • GNE N/A
  • Revenue Next Year
  • XYLO $5.71
  • GNE N/A
  • P/E Ratio
  • XYLO N/A
  • GNE $24.68
  • Revenue Growth
  • XYLO N/A
  • GNE N/A
  • 52 Week Low
  • XYLO $2.70
  • GNE $13.05
  • 52 Week High
  • XYLO $8.83
  • GNE $17.93
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 51.98
  • GNE 71.06
  • Support Level
  • XYLO $5.19
  • GNE $14.64
  • Resistance Level
  • XYLO $5.73
  • GNE $16.50
  • Average True Range (ATR)
  • XYLO 0.35
  • GNE 0.51
  • MACD
  • XYLO -0.01
  • GNE 0.15
  • Stochastic Oscillator
  • XYLO 42.48
  • GNE 98.87

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: